Propranolol for Hypertension and Angina
Dosing for Angina Pectoris
For angina, start propranolol at 20-80 mg twice daily and titrate upward to achieve a resting heart rate of 50-60 beats per minute, with typical effective doses ranging from 160-320 mg daily in divided doses. 1
- Propranolol lacks beta-1 selectivity, meaning it blocks both cardiac (beta-1) and bronchial/vascular (beta-2) receptors 1
- The drug has no intrinsic sympathomimetic activity, which is preferred for acute coronary syndromes 1
- Studies in acute settings have validated propranolol alongside metoprolol and atenolol for unstable angina/NSTEMI 1
Intravenous Administration for Acute Angina
- Give 0.5-1.0 mg IV as initial dose, followed in 1-2 hours by 40-80 mg orally every 6-8 hours 1
- IV administration may be warranted for ongoing rest pain with tachycardia or hypertension 1, 2
- Monitor heart rate, blood pressure, and ECG continuously during IV therapy 1
Oral Dosing Strategy
- Extended-release formulation: start 80 mg once daily, increase to 120-160 mg once daily for maintenance 3
- Average optimal dose for angina appears to be 160 mg once daily with extended-release formulation 3
- Maximum studied dose is 320 mg daily; safety beyond this has not been established 3
- Dose-response studies show progressive reduction in angina attacks up to 417 mg daily average dose 4
Dosing for Hypertension
For hypertension, initiate propranolol extended-release at 80 mg once daily and titrate to 120-160 mg once daily for maintenance, with maximum doses up to 640 mg daily if needed. 3
- Usual maintenance dose is 120-160 mg once daily 3
- Full hypertensive response may take several days to weeks 3
- Extended-release formulation provides sustained beta-blockade over 24 hours with once-daily dosing 5
Important Conversion Considerations
- Propranolol extended-release is NOT a simple mg-for-mg substitute for immediate-release formulation 3
- Extended-release produces lower blood levels than equivalent doses of immediate-release 3
- When switching from immediate-release to extended-release, retitration upward may be necessary 3
- Metoprolol 50 mg twice daily is approximately equivalent to propranolol 80-100 mg twice daily 6
Absolute Contraindications
Do not administer propranolol in patients with marked AV block (PR >0.24s), second- or third-degree heart block without pacemaker, history of asthma, severe LV dysfunction/heart failure, or high risk for cardiogenic shock. 1, 7
- Patients with systolic BP <90 mmHg should not receive acute beta-blocker therapy 1, 7
- Heart rate <50 bpm is a contraindication to acute administration 1, 7
- Evidence of low-output state (oliguria) requires resolution before initiating therapy 1, 7
- Risk factors for cardiogenic shock include older age, female sex, higher Killip class, lower BP, and higher heart rate 7
Special Populations and Precautions
Chronic Obstructive Pulmonary Disease
- Use propranolol very cautiously in COPD patients with reactive airway component 1, 2
- If beta-blocker is needed in patients with mild wheezing or COPD, choose a beta-1 selective agent like metoprolol at reduced dose (12.5 mg) rather than propranolol 1
- Propranolol's non-selective blockade causes bronchoconstriction via beta-2 receptor inhibition 2, 8, 2
Heart Failure Considerations
- Beta-blockers are strongly recommended before discharge in patients with compensated HF or LV systolic dysfunction for secondary prevention 1, 7
- Avoid in acute decompensated heart failure (rales, S3 gallop) 1, 7
- Early aggressive beta-blockade poses substantial hazard in hemodynamically unstable patients 2, 7
Mechanism of Action and Clinical Effects
- Propranolol reduces myocardial oxygen demand by decreasing heart rate, systolic blood pressure, and myocardial contractility 2, 8, 2
- Slowing heart rate increases diastolic duration, improving coronary perfusion and collateral flow 2
- In angina, propranolol delays onset of pain and increases work capacity during exercise 3
- Antihypertensive effects may involve decreased cardiac output, renin inhibition, and reduced sympathetic outflow 3
Pharmacokinetics
- Propranolol is highly lipophilic with nearly complete oral absorption but undergoes extensive first-pass metabolism 3
- Only 25% reaches systemic circulation on average 3
- Extended-release formulation peaks at approximately 6 hours 3
- Terminal half-life of extended-release is 8-11 hours vs. shorter for immediate-release 5
- 90% protein bound (albumin and alpha-1-acid glycoprotein) 3
Critical Warnings
Abrupt Discontinuation
- Never abruptly discontinue propranolol—taper gradually over several weeks to prevent rebound hypertension, worsening angina, myocardial infarction, and ventricular arrhythmias 3, 9
- Sudden withdrawal eliminates therapeutic benefit and may precipitate acute myocardial ischemia 9
Drug Interactions
- Propranolol increases nifedipine concentrations by 64% (Cmax) and 79% (AUC) 3
- Cimetidine increases propranolol AUC by 46% and Cmax by 35% 3
- Cholestyramine or colestipol decrease propranolol concentrations up to 50% 3
- Propranolol increases warfarin bioavailability and prothrombin time 3
- Zolmitriptan AUC increases 56% and rizatriptan AUC increases 67% when combined with propranolol 3
Monitoring Parameters
- Target resting heart rate: 50-60 beats per minute unless limiting side effects occur 1, 8
- Check blood pressure approximately 5 minutes after local anesthesia in dental procedures to detect hypertensive response 9
- Monitor for signs of heart failure, bronchospasm, and hypotension during initiation 1
- In hypertensive emergency from propranolol-epinephrine interaction, use phentolamine 5 mg IV or sublingual nitroglycerin 0.4 mg 9